Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Sexual Dysfunction in Gynecologic Oncology
NCT03801031Phase 4Terminated
- Start
- Jun 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in sexual dysfunction (2 arms). Primary endpoints: Changes in Sexual Function at 9 months and Changes in Pain at 9 months. Started Jun 2019; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
sexual dysfunction
Beyond the preview
Go deeper on NCT03801031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801031.